世界の男性乳がん治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Male Breast Cancer Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4456
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、109ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、男性乳がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（投薬、化学療法、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・男性乳がん治療の市場動向
・企業の競争状況、市場シェア
・男性乳がん治療の種類別市場規模と予測2016-2027（投薬、化学療法、その他）
・男性乳がん治療の用途別市場規模と予測2016-2027（病院、クリニック、その他）
・男性乳がん治療の北米市場規模2016-2027（アメリカ、カナダ）
・男性乳がん治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・男性乳がん治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・男性乳がん治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・男性乳がん治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Pfizer、Roche、GlaxoSmithKline、Sanofi、Novartis、Bayer、Bristol-Myers Squibb、Eli Lilly、AstraZeneca、Teva Pharmaceutical、Sun Pharmaceutical、BioNumerik Pharmaceuticals、Seattle Genetics、Accord Healthcare）
・結論

Male breast cancer (male breast neoplasm) is a rare cancer in males that originates from the breast. Many males with breast cancer have inherited a BRCA mutation, but there are other causes, including alcohol abuse and exposure to certain hormones and ionizing radiation.

Market Analysis and Insights: Global Male Breast Cancer Treatment Market
The global Male Breast Cancer Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Male Breast Cancer Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Male Breast Cancer Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Male Breast Cancer Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Male Breast Cancer Treatment market.

Global Male Breast Cancer Treatment Scope and Market Size
Male Breast Cancer Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Male Breast Cancer Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Medication
Chemotherapy
Others

Segment by Application
Hospitals
Clinics
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer
Roche
GlaxoSmithKline
Sanofi
Novartis
Bayer
Bristol-Myers Squibb
Eli Lilly
AstraZeneca
Teva Pharmaceutical
Sun Pharmaceutical
BioNumerik Pharmaceuticals
Seattle Genetics
Accord Healthcare

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Male Breast Cancer Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Medication
1.2.3 Chemotherapy
1.2.4 Others
1.3 Market by Application
1.3.1 Global Male Breast Cancer Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Male Breast Cancer Treatment Market Perspective (2016-2027)
2.2 Male Breast Cancer Treatment Growth Trends by Regions
2.2.1 Male Breast Cancer Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Male Breast Cancer Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Male Breast Cancer Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Male Breast Cancer Treatment Industry Dynamic
2.3.1 Male Breast Cancer Treatment Market Trends
2.3.2 Male Breast Cancer Treatment Market Drivers
2.3.3 Male Breast Cancer Treatment Market Challenges
2.3.4 Male Breast Cancer Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Male Breast Cancer Treatment Players by Revenue
3.1.1 Global Top Male Breast Cancer Treatment Players by Revenue (2016-2021)
3.1.2 Global Male Breast Cancer Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Male Breast Cancer Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Male Breast Cancer Treatment Revenue
3.4 Global Male Breast Cancer Treatment Market Concentration Ratio
3.4.1 Global Male Breast Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Male Breast Cancer Treatment Revenue in 2020
3.5 Male Breast Cancer Treatment Key Players Head office and Area Served
3.6 Key Players Male Breast Cancer Treatment Product Solution and Service
3.7 Date of Enter into Male Breast Cancer Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Male Breast Cancer Treatment Breakdown Data by Type
4.1 Global Male Breast Cancer Treatment Historic Market Size by Type (2016-2021)
4.2 Global Male Breast Cancer Treatment Forecasted Market Size by Type (2022-2027)

5 Male Breast Cancer Treatment Breakdown Data by Application
5.1 Global Male Breast Cancer Treatment Historic Market Size by Application (2016-2021)
5.2 Global Male Breast Cancer Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Male Breast Cancer Treatment Market Size (2016-2027)
6.2 North America Male Breast Cancer Treatment Market Size by Type
6.2.1 North America Male Breast Cancer Treatment Market Size by Type (2016-2021)
6.2.2 North America Male Breast Cancer Treatment Market Size by Type (2022-2027)
6.2.3 North America Male Breast Cancer Treatment Market Size by Type (2016-2027)
6.3 North America Male Breast Cancer Treatment Market Size by Application
6.3.1 North America Male Breast Cancer Treatment Market Size by Application (2016-2021)
6.3.2 North America Male Breast Cancer Treatment Market Size by Application (2022-2027)
6.3.3 North America Male Breast Cancer Treatment Market Size by Application (2016-2027)
6.4 North America Male Breast Cancer Treatment Market Size by Country
6.4.1 North America Male Breast Cancer Treatment Market Size by Country (2016-2021)
6.4.2 North America Male Breast Cancer Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Male Breast Cancer Treatment Market Size (2016-2027)
7.2 Europe Male Breast Cancer Treatment Market Size by Type
7.2.1 Europe Male Breast Cancer Treatment Market Size by Type (2016-2021)
7.2.2 Europe Male Breast Cancer Treatment Market Size by Type (2022-2027)
7.2.3 Europe Male Breast Cancer Treatment Market Size by Type (2016-2027)
7.3 Europe Male Breast Cancer Treatment Market Size by Application
7.3.1 Europe Male Breast Cancer Treatment Market Size by Application (2016-2021)
7.3.2 Europe Male Breast Cancer Treatment Market Size by Application (2022-2027)
7.3.3 Europe Male Breast Cancer Treatment Market Size by Application (2016-2027)
7.4 Europe Male Breast Cancer Treatment Market Size by Country
7.4.1 Europe Male Breast Cancer Treatment Market Size by Country (2016-2021)
7.4.2 Europe Male Breast Cancer Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Male Breast Cancer Treatment Market Size (2016-2027)
8.2 Asia-Pacific Male Breast Cancer Treatment Market Size by Type
8.2.1 Asia-Pacific Male Breast Cancer Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Male Breast Cancer Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Male Breast Cancer Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Male Breast Cancer Treatment Market Size by Application
8.3.1 Asia-Pacific Male Breast Cancer Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Male Breast Cancer Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Male Breast Cancer Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Male Breast Cancer Treatment Market Size by Region
8.4.1 Asia-Pacific Male Breast Cancer Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Male Breast Cancer Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Male Breast Cancer Treatment Market Size (2016-2027)
9.2 Latin America Male Breast Cancer Treatment Market Size by Type
9.2.1 Latin America Male Breast Cancer Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Male Breast Cancer Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Male Breast Cancer Treatment Market Size by Type (2016-2027)
9.3 Latin America Male Breast Cancer Treatment Market Size by Application
9.3.1 Latin America Male Breast Cancer Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Male Breast Cancer Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Male Breast Cancer Treatment Market Size by Application (2016-2027)
9.4 Latin America Male Breast Cancer Treatment Market Size by Country
9.4.1 Latin America Male Breast Cancer Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Male Breast Cancer Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Male Breast Cancer Treatment Market Size (2016-2027)
10.2 Middle East & Africa Male Breast Cancer Treatment Market Size by Type
10.2.1 Middle East & Africa Male Breast Cancer Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Male Breast Cancer Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Male Breast Cancer Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Male Breast Cancer Treatment Market Size by Application
10.3.1 Middle East & Africa Male Breast Cancer Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Male Breast Cancer Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Male Breast Cancer Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Male Breast Cancer Treatment Market Size by Country
10.4.1 Middle East & Africa Male Breast Cancer Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Male Breast Cancer Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Male Breast Cancer Treatment Introduction
11.1.4 Pfizer Revenue in Male Breast Cancer Treatment Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Male Breast Cancer Treatment Introduction
11.2.4 Roche Revenue in Male Breast Cancer Treatment Business (2016-2021)
11.2.5 Roche Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Details
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Male Breast Cancer Treatment Introduction
11.3.4 GlaxoSmithKline Revenue in Male Breast Cancer Treatment Business (2016-2021)
11.3.5 GlaxoSmithKline Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Details
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Male Breast Cancer Treatment Introduction
11.4.4 Sanofi Revenue in Male Breast Cancer Treatment Business (2016-2021)
11.4.5 Sanofi Recent Development
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Male Breast Cancer Treatment Introduction
11.5.4 Novartis Revenue in Male Breast Cancer Treatment Business (2016-2021)
11.5.5 Novartis Recent Development
11.6 Bayer
11.6.1 Bayer Company Details
11.6.2 Bayer Business Overview
11.6.3 Bayer Male Breast Cancer Treatment Introduction
11.6.4 Bayer Revenue in Male Breast Cancer Treatment Business (2016-2021)
11.6.5 Bayer Recent Development
11.7 Bristol-Myers Squibb
11.7.1 Bristol-Myers Squibb Company Details
11.7.2 Bristol-Myers Squibb Business Overview
11.7.3 Bristol-Myers Squibb Male Breast Cancer Treatment Introduction
11.7.4 Bristol-Myers Squibb Revenue in Male Breast Cancer Treatment Business (2016-2021)
11.7.5 Bristol-Myers Squibb Recent Development
11.8 Eli Lilly
11.8.1 Eli Lilly Company Details
11.8.2 Eli Lilly Business Overview
11.8.3 Eli Lilly Male Breast Cancer Treatment Introduction
11.8.4 Eli Lilly Revenue in Male Breast Cancer Treatment Business (2016-2021)
11.8.5 Eli Lilly Recent Development
11.9 AstraZeneca
11.9.1 AstraZeneca Company Details
11.9.2 AstraZeneca Business Overview
11.9.3 AstraZeneca Male Breast Cancer Treatment Introduction
11.9.4 AstraZeneca Revenue in Male Breast Cancer Treatment Business (2016-2021)
11.9.5 AstraZeneca Recent Development
11.10 Teva Pharmaceutical
11.10.1 Teva Pharmaceutical Company Details
11.10.2 Teva Pharmaceutical Business Overview
11.10.3 Teva Pharmaceutical Male Breast Cancer Treatment Introduction
11.10.4 Teva Pharmaceutical Revenue in Male Breast Cancer Treatment Business (2016-2021)
11.10.5 Teva Pharmaceutical Recent Development
11.11 Sun Pharmaceutical
11.11.1 Sun Pharmaceutical Company Details
11.11.2 Sun Pharmaceutical Business Overview
11.11.3 Sun Pharmaceutical Male Breast Cancer Treatment Introduction
11.11.4 Sun Pharmaceutical Revenue in Male Breast Cancer Treatment Business (2016-2021)
11.11.5 Sun Pharmaceutical Recent Development
11.12 BioNumerik Pharmaceuticals
11.12.1 BioNumerik Pharmaceuticals Company Details
11.12.2 BioNumerik Pharmaceuticals Business Overview
11.12.3 BioNumerik Pharmaceuticals Male Breast Cancer Treatment Introduction
11.12.4 BioNumerik Pharmaceuticals Revenue in Male Breast Cancer Treatment Business (2016-2021)
11.12.5 BioNumerik Pharmaceuticals Recent Development
11.13 Seattle Genetics
11.13.1 Seattle Genetics Company Details
11.13.2 Seattle Genetics Business Overview
11.13.3 Seattle Genetics Male Breast Cancer Treatment Introduction
11.13.4 Seattle Genetics Revenue in Male Breast Cancer Treatment Business (2016-2021)
11.13.5 Seattle Genetics Recent Development
11.14 Accord Healthcare
11.14.1 Accord Healthcare Company Details
11.14.2 Accord Healthcare Business Overview
11.14.3 Accord Healthcare Male Breast Cancer Treatment Introduction
11.14.4 Accord Healthcare Revenue in Male Breast Cancer Treatment Business (2016-2021)
11.14.5 Accord Healthcare Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Male Breast Cancer Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Medication
Table 3. Key Players of Chemotherapy
Table 4. Key Players of Others
Table 5. Global Male Breast Cancer Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Male Breast Cancer Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Male Breast Cancer Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Male Breast Cancer Treatment Market Share by Regions (2016-2021)
Table 9. Global Male Breast Cancer Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Male Breast Cancer Treatment Market Share by Regions (2022-2027)
Table 11. Male Breast Cancer Treatment Market Trends
Table 12. Male Breast Cancer Treatment Market Drivers
Table 13. Male Breast Cancer Treatment Market Challenges
Table 14. Male Breast Cancer Treatment Market Restraints
Table 15. Global Male Breast Cancer Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Male Breast Cancer Treatment Market Share by Players (2016-2021)
Table 17. Global Top Male Breast Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Male Breast Cancer Treatment as of 2020)
Table 18. Ranking of Global Top Male Breast Cancer Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Male Breast Cancer Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Male Breast Cancer Treatment Product Solution and Service
Table 22. Date of Enter into Male Breast Cancer Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Male Breast Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Male Breast Cancer Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Male Breast Cancer Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Male Breast Cancer Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Male Breast Cancer Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Male Breast Cancer Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Male Breast Cancer Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Male Breast Cancer Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Male Breast Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Male Breast Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Male Breast Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Male Breast Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Male Breast Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Male Breast Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Male Breast Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Male Breast Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Male Breast Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Male Breast Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Male Breast Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Male Breast Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Male Breast Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Male Breast Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Male Breast Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Male Breast Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Male Breast Cancer Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Male Breast Cancer Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Male Breast Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Male Breast Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Male Breast Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Male Breast Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Male Breast Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Male Breast Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Male Breast Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Male Breast Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Male Breast Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Male Breast Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Male Breast Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Male Breast Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. Pfizer Company Details
Table 63. Pfizer Business Overview
Table 64. Pfizer Male Breast Cancer Treatment Product
Table 65. Pfizer Revenue in Male Breast Cancer Treatment Business (2016-2021) & (US$ Million)
Table 66. Pfizer Recent Development
Table 67. Roche Company Details
Table 68. Roche Business Overview
Table 69. Roche Male Breast Cancer Treatment Product
Table 70. Roche Revenue in Male Breast Cancer Treatment Business (2016-2021) & (US$ Million)
Table 71. Roche Recent Development
Table 72. GlaxoSmithKline Company Details
Table 73. GlaxoSmithKline Business Overview
Table 74. GlaxoSmithKline Male Breast Cancer Treatment Product
Table 75. GlaxoSmithKline Revenue in Male Breast Cancer Treatment Business (2016-2021) & (US$ Million)
Table 76. GlaxoSmithKline Recent Development
Table 77. Sanofi Company Details
Table 78. Sanofi Business Overview
Table 79. Sanofi Male Breast Cancer Treatment Product
Table 80. Sanofi Revenue in Male Breast Cancer Treatment Business (2016-2021) & (US$ Million)
Table 81. Sanofi Recent Development
Table 82. Novartis Company Details
Table 83. Novartis Business Overview
Table 84. Novartis Male Breast Cancer Treatment Product
Table 85. Novartis Revenue in Male Breast Cancer Treatment Business (2016-2021) & (US$ Million)
Table 86. Novartis Recent Development
Table 87. Bayer Company Details
Table 88. Bayer Business Overview
Table 89. Bayer Male Breast Cancer Treatment Product
Table 90. Bayer Revenue in Male Breast Cancer Treatment Business (2016-2021) & (US$ Million)
Table 91. Bayer Recent Development
Table 92. Bristol-Myers Squibb Company Details
Table 93. Bristol-Myers Squibb Business Overview
Table 94. Bristol-Myers Squibb Male Breast Cancer Treatment Product
Table 95. Bristol-Myers Squibb Revenue in Male Breast Cancer Treatment Business (2016-2021) & (US$ Million)
Table 96. Bristol-Myers Squibb Recent Development
Table 97. Eli Lilly Company Details
Table 98. Eli Lilly Business Overview
Table 99. Eli Lilly Revenue in Male Breast Cancer Treatment Business (2016-2021) & (US$ Million)
Table 100. Eli Lilly Recent Development
Table 101. AstraZeneca Company Details
Table 102. AstraZeneca Business Overview
Table 103. AstraZeneca Male Breast Cancer Treatment Product
Table 104. AstraZeneca Revenue in Male Breast Cancer Treatment Business (2016-2021) & (US$ Million)
Table 105. AstraZeneca Recent Development
Table 106. Teva Pharmaceutical Company Details
Table 107. Teva Pharmaceutical Business Overview
Table 108. Teva Pharmaceutical Male Breast Cancer Treatment Product
Table 109. Teva Pharmaceutical Revenue in Male Breast Cancer Treatment Business (2016-2021) & (US$ Million)
Table 110. Teva Pharmaceutical Recent Development
Table 111. Sun Pharmaceutical Company Details
Table 112. Sun Pharmaceutical Business Overview
Table 113. Sun Pharmaceutical Male Breast Cancer Treatment Product
Table 114. Sun Pharmaceutical Revenue in Male Breast Cancer Treatment Business (2016-2021) & (US$ Million)
Table 115. Sun Pharmaceutical Recent Development
Table 116. BioNumerik Pharmaceuticals Company Details
Table 117. BioNumerik Pharmaceuticals Business Overview
Table 118. BioNumerik Pharmaceuticals Male Breast Cancer Treatment Product
Table 119. BioNumerik Pharmaceuticals Revenue in Male Breast Cancer Treatment Business (2016-2021) & (US$ Million)
Table 120. BioNumerik Pharmaceuticals Recent Development
Table 121. Seattle Genetics Company Details
Table 122. Seattle Genetics Business Overview
Table 123. Seattle Genetics Male Breast Cancer Treatment Product
Table 124. Seattle Genetics Revenue in Male Breast Cancer Treatment Business (2016-2021) & (US$ Million)
Table 125. Seattle Genetics Recent Development
Table 126. Accord Healthcare Company Details
Table 127. Accord Healthcare Business Overview
Table 128. Accord Healthcare Male Breast Cancer Treatment Product
Table 129. Accord Healthcare Revenue in Male Breast Cancer Treatment Business (2016-2021) & (US$ Million)
Table 130. Accord Healthcare Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Male Breast Cancer Treatment Market Share by Type: 2020 VS 2027
Figure 2. Medication Features
Figure 3. Chemotherapy Features
Figure 4. Others Features
Figure 5. Global Male Breast Cancer Treatment Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Others Case Studies
Figure 9. Male Breast Cancer Treatment Report Years Considered
Figure 10. Global Male Breast Cancer Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Male Breast Cancer Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Male Breast Cancer Treatment Market Share by Regions: 2020 VS 2027
Figure 13. Global Male Breast Cancer Treatment Market Share by Regions (2022-2027)
Figure 14. Global Male Breast Cancer Treatment Market Share by Players in 2020
Figure 15. Global Top Male Breast Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Male Breast Cancer Treatment as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Male Breast Cancer Treatment Revenue in 2020
Figure 17. Global Male Breast Cancer Treatment Revenue Market Share by Type (2016-2021)
Figure 18. Global Male Breast Cancer Treatment Revenue Market Share by Type (2022-2027)
Figure 19. North America Male Breast Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Male Breast Cancer Treatment Market Share by Type (2016-2027)
Figure 21. North America Male Breast Cancer Treatment Market Share by Application (2016-2027)
Figure 22. North America Male Breast Cancer Treatment Market Share by Country (2016-2027)
Figure 23. United States Male Breast Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Male Breast Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Male Breast Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Male Breast Cancer Treatment Market Share by Type (2016-2027)
Figure 27. Europe Male Breast Cancer Treatment Market Share by Application (2016-2027)
Figure 28. Europe Male Breast Cancer Treatment Market Share by Country (2016-2027)
Figure 29. Germany Male Breast Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Male Breast Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Male Breast Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Male Breast Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Male Breast Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Male Breast Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Male Breast Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Male Breast Cancer Treatment Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Male Breast Cancer Treatment Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Male Breast Cancer Treatment Market Share by Region (2016-2027)
Figure 39. China Male Breast Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Male Breast Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Male Breast Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Male Breast Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Male Breast Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Male Breast Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Male Breast Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Male Breast Cancer Treatment Market Share by Type (2016-2027)
Figure 47. Latin America Male Breast Cancer Treatment Market Share by Application (2016-2027)
Figure 48. Latin America Male Breast Cancer Treatment Market Share by Country (2016-2027)
Figure 49. Mexico Male Breast Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Male Breast Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Male Breast Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Male Breast Cancer Treatment Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Male Breast Cancer Treatment Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Male Breast Cancer Treatment Market Share by Country (2016-2027)
Figure 55. Turkey Male Breast Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Male Breast Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Male Breast Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Pfizer Revenue Growth Rate in Male Breast Cancer Treatment Business (2016-2021)
Figure 59. Roche Revenue Growth Rate in Male Breast Cancer Treatment Business (2016-2021)
Figure 60. GlaxoSmithKline Revenue Growth Rate in Male Breast Cancer Treatment Business (2016-2021)
Figure 61. Sanofi Revenue Growth Rate in Male Breast Cancer Treatment Business (2016-2021)
Figure 62. Novartis Revenue Growth Rate in Male Breast Cancer Treatment Business (2016-2021)
Figure 63. Bayer Revenue Growth Rate in Male Breast Cancer Treatment Business (2016-2021)
Figure 64. Bristol-Myers Squibb Revenue Growth Rate in Male Breast Cancer Treatment Business (2016-2021)
Figure 65. Eli Lilly Revenue Growth Rate in Male Breast Cancer Treatment Business (2016-2021)
Figure 66. AstraZeneca Revenue Growth Rate in Male Breast Cancer Treatment Business (2016-2021)
Figure 67. Teva Pharmaceutical Revenue Growth Rate in Male Breast Cancer Treatment Business (2016-2021)
Figure 68. Sun Pharmaceutical Revenue Growth Rate in Male Breast Cancer Treatment Business (2016-2021)
Figure 69. BioNumerik Pharmaceuticals Revenue Growth Rate in Male Breast Cancer Treatment Business (2016-2021)
Figure 70. Seattle Genetics Revenue Growth Rate in Male Breast Cancer Treatment Business (2016-2021)
Figure 71. Accord Healthcare Revenue Growth Rate in Male Breast Cancer Treatment Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

以下、関連資料のご紹介

世界の転移性乳がん治療市場規模・現状・予測（2021年-2027年）

Global Metastatic Breast Cancer Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4496 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、転移性乳がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、放射線療法、生物学的標的療法、乳腺手術、ホルモン療法）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、...

世界の乳房乳腺腫瘤摘出術治療市場規模・現状・予測（2021年-2027年）

Global Breast Lumpectomy Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3942 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、乳房乳腺腫瘤摘出術治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（乳がんステージI、乳がんステージII、その他）、用途別市場規模（病院、診療所、外来外科センター、研究所・学術センター、その他）、主...

世界の乳がん小線源治療市場規模・現状・予測（2021年-2027年）

Global Breast Cancer Brachytherapy Market Size, Status and Forecast 2021-2027
QFJ1-3936 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、乳がん小線源治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（高線量率、低線量率）、用途別市場規模（医療、バイオテクノロジー、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、...

世界の乳がん診断市場規模・現状・予測（2021年-2027年）

Global Breast Cancer Diagnostic Market Size, Status and Forecast 2021-2027
QFJ1-3937 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、乳がん診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（画像、生検、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南...

世界の乳がん分子病理学診断市場規模・現状・予測（2021年-2027年）

Global Breast Cancer Molecular Diagnostics Market Size, Status and Forecast 2021-2027
QFJ1-3939 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、乳がん分子病理学診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究所）、主要地域別市場規模（...

世界の乳がん検査市場規模・現状・予測（2021年-2027年）

Global Breast Cancer Testing Market Size, Status and Forecast 2021-2027
QFJ1-3940 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、乳がん検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（スクリーニング検査、診断検査、モニタリング検査）、用途別市場規模（非浸潤性乳がん、浸潤性乳がん）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界の乳がん診断＆薬物技術市場規模・現状・予測（2021年-2027年）

Global Breast Cancer Diagnostic and Drug Technologies Market Size, Status and Forecast 2021-2027
QFJ1-3938 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、乳がん診断＆薬物技術の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（マンモグラフィ、生検、その他）、用途別市場規模（乳管癌、浸潤性乳管癌、小葉癌、トリプルネガティブ乳がん）、主要地域別市場規模（北米、...

世界のホルモン不応性乳がん市場規模・現状・予測（2021年-2027年）

Global Hormone Refractory Breast Cancer Market Size, Status and Forecast 2021-2027
QFJ1-4319 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、ホルモン不応性乳がんの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（腫瘍マーカー療法、遺伝子発現療法、遺伝子変異療法）、用途別市場規模（科学研究生産、生物科学技術、医療技術、医療機器）、主要地域別市場...

世界の乳房嚢胞治療市場規模・現状・予測（2021年-2027年）

Global Breast Cyst Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3941 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、乳房嚢胞治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（手術、放射線療法、穿刺吸引生検、ホルモン療法）、用途別市場規模（病院、診療所、外来外科センター、その他）、主要地域別市場規模（北米、アメリカ...

世界の乳がん再発スコア検査市場規模・現状・予測（2021年-2027年）

Global Breast Cancer Recurrence Score Test Market Size, Status and Forecast 2021-2027
QFJ1-5112 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、乳がん再発スコア検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（I期の浸潤性乳がん、II期の浸潤性乳がん、エストロゲン受容体陽性がん、リンパ節転移陰性乳がん）、用途別市場規模（病院、専門がんセンタ...

世界の転移性乳がん治療市場規模・現状・予測（2021年-2027年） Metastatic breast cancer is an advanced stage of breast cancer. It involves cases in which breast cancer has spread to the other parts of the body. Some of the most common organs which are affected by metastatic breast cancer are brain, liver, bones and lungs. It is also known as stage IV breast can…
世界の乳房乳腺腫瘤摘出術治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Breast Lumpectomy Treatment Market The global Breast Lumpectomy Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity…
世界の乳がん診断市場規模・現状・予測（2021年-2027年） Breast cancer can be diagnosed through multiple tests, including a mammogram, ultrasound, MRI and biopsy. Market Analysis and Insights: Global Breast Cancer Diagnostic Market The global Breast Cancer Diagnostic market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, a…
世界の乳がん小線源治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Breast Cancer Brachytherapy Market The global Breast Cancer Brachytherapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity…
世界の転移性骨がん薬物治療市場規模・現状・予測（2021年-2027年） Bone metastasis occurs when cancer cells spread from their original site to a bone. Nearly all types ofcancer can spread (metastasize) to the bones. But some types of cancer are particularly likely to spread to bone, including breast cancer and prostatecancer Market Analysis and Insights: Global Met…